Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
- PMID: 8595487
- DOI: 10.1093/brain/118.6.1583
Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss
Erratum in
- Brain 1996 Aug;119(Pt 4):1415
Abstract
Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in 11 patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease, eight patients with autosomal dominant cerebellar ataxia (ADCA) and 11 healthy controls. In all subjects MRS was localized to cerebellar white matter (volumes of interest 3-6 ml). Apparent metabolite concentrations were calculated using the fully relaxed water spectrum as an internal standard of reference. The patients also underwent MRI to assess cerebellar volume and (in the two multiple sclerosis groups) lesion volume within the posterior fossa. Magnetic resonance spectroscopy from cerebellar white matter showed a highly significant reduction in the concentration of N-acetyl groups (NA) [which consists predominantly of N-acetylaspartate (NAA), a neuronal marker] in the multiple sclerosis group with cerebellar deficit compared with the multiple sclerosis group with minimal or no signs of cerebellar involvement, and healthy controls. Follow-up MRS performed in six of the multiple sclerosis patients 9 months later showed no change in the median NA concentration. The ADCA group showed a significant reduction of NA from a region of cerebellar white matter and also a reduction in the concentration of choline-containing compounds. The multiple sclerosis group with severe cerebellar deficit and the ADCA group both had significant cerebellar atrophy (suggesting nerve cell body and axon loss) compared with the multiple sclerosis patients with minimal or no signs of cerebellar deficit and healthy controls. The multiple sclerosis patients with cerebellar deficit had a significantly greater lesion volume in the posterior fossa, although the proportion of the spectroscopic voxel occupied by lesions was small, suggesting that axonal loss from normal appearing white matter also contributes to the observed reduction in NA. These results support the hypothesis that axonal loss is important in the development of persistent clinical disability in multiple sclerosis.
Comment in
-
MRI and assessment of treatment in multiple sclerosis.Brain. 2001 May;124(Pt 5):1052-3. doi: 10.1093/brain/124.5.1052. Brain. 2001. PMID: 11335707 No abstract available.
Similar articles
-
1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis.J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):736-42. doi: 10.1136/jnnp.63.6.736. J Neurol Neurosurg Psychiatry. 1997. PMID: 9416807 Free PMC article. Clinical Trial.
-
Imaging axonal damage of normal-appearing white matter in multiple sclerosis.Brain. 1998 Jan;121 ( Pt 1):103-13. doi: 10.1093/brain/121.1.103. Brain. 1998. PMID: 9549491
-
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.Brain. 1994 Feb;117 ( Pt 1):49-58. doi: 10.1093/brain/117.1.49. Brain. 1994. PMID: 8149214
-
The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis.Ital J Neurol Sci. 1999;20(5 Suppl):S241-5. doi: 10.1007/s100729970004. Ital J Neurol Sci. 1999. PMID: 10662956 Review.
-
[Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].Nihon Rinsho. 2003 Aug;61(8):1435-41. Nihon Rinsho. 2003. PMID: 12962035 Review. Japanese.
Cited by
-
Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression.CNS Drugs. 2001;15(6):427-36. doi: 10.2165/00023210-200115060-00001. CNS Drugs. 2001. PMID: 11524021 Review.
-
Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis.Exp Brain Res. 2004 Sep;158(1):1-8. doi: 10.1007/s00221-004-1867-4. Epub 2004 Apr 29. Exp Brain Res. 2004. PMID: 15118796
-
Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.Ital J Neurol Sci. 1996 Dec;17(6):385-91. doi: 10.1007/BF01997712. Ital J Neurol Sci. 1996. PMID: 8978444 Review.
-
Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.J Mol Neurosci. 2015 Mar;55(3):733-48. doi: 10.1007/s12031-014-0412-6. Epub 2014 Sep 5. J Mol Neurosci. 2015. PMID: 25189319
-
Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup?J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):710-5. doi: 10.1136/jnnp.67.6.710. J Neurol Neurosurg Psychiatry. 1999. PMID: 10567484 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical